Browse > Article
http://dx.doi.org/10.15616/BSL.2018.24.3.143

Catechol Estrogen 4-Hydroxyestradiol is an Ultimate Carcinogen in Breast Cancer  

Park, Sin-Aye (Department of Biomedical Laboratory Science, College of Medical Sciences, Soonchunhyang University)
Publication Information
Biomedical Science Letters / v.24, no.3, 2018 , pp. 143-149 More about this Journal
Abstract
Excessive exposure to estrogens is the most important risk factor for the development of hormone-sensitive cancers, especially breast cancer. Estrogen stimulates the expression of genes and proteins involved in cell proliferation by binding to estrogen receptor (ER). Another possible mechanism of ER-independent carcinogenicity of estrogens is based on the hydroxylation of estradiol resulting in the formation of catechol estrogens. Catechol estrogen 4-hydroxyestradiol ($4-OHE_2$) is further oxidized to catechol estrogen-3,4-quinones, the major carcinogenic metabolites of estrogens. Evidence increasingly supports the critical role of $4-OHE_2$ in hormonal carcinogenesis via DNA adduct formation or production of reactive oxygen species, which finally contribute to the transformation of normal mammary epithelial cells and the enhanced growth of breast cancer cells. It is also reported that the level of $4-OHE_2$ or its quinones is highly up-regulated in urine or tissues of breast cancer patients. Thus, we highlight the oncogenic roles of $4-OHE_2$ in catechol estrogen-induced breast carcinogenesis.
Keywords
Breast cancer; Catechol estrogen-3,4-quinones; DNA adducts; 4-Hydroxyestradiol; Reactive oxygen species;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Cavalieri EL, Stack DE, Devanesan PD, Todorovic R, Dwivedy I, Higginbotham S, Johansson SL, Patil KD, Gross ML, Gooden JK, Ramanathan R, Cerny RL, Rogan EG. Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci U S A. 1997. 94: 10937-10942.   DOI
2 Zhang Y, Gaikwad NW, Olson K, Zahid M, Cavalieri EL, Rogan EG. Cytochrome p450 isoforms catalyze formation of catechol estrogen quinones that react with DNA. Metabolism. 2007. 56: 887-894.   DOI
3 Zhao Z, Kosinska W, Khmelnitsky M, Cavalieri EL, Rogan EG, Chakravarti D, Sacks PG, Guttenplan JB. Mutagenic activity of 4-hydroxyestradiol, but not 2-hydroxyestradiol, in bb rat2 embryonic cells, and the mutational spectrum of 4-hydroxyestradiol. Chem Res Toxicol. 2006. 19: 475-479.   DOI
4 Zheng W, Xie DW, Jin F, Cheng JR, Dai Q, Wen WQ, Shu XO, Gao YT. Genetic polymorphism of cytochrome p450-1b1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2000. 9: 147-150.
5 Zhu BT, Conney AH. Functional role of estrogen metabolism in target cells: Review and perspectives. Carcinogenesis. 1998. 19: 1-27.   DOI
6 Chakravarti D, Mailander PC, Li KM, Higginbotham S, Zhang HL, Gross ML, Meza JL, Cavalieri EL, Rogan EG. Evidence that a burst of DNA depurination in sencar mouse skin induces error-prone repair and forms mutations in the h-ras gene. Oncogene. 2001. 20: 7945-7953.   DOI
7 Chang M. Dual roles of estrogen metabolism in mammary carcinogenesis. BMB Rep. 2011. 44: 423-434.   DOI
8 Chen ZH, Na HK, Hurh YJ, Surh YJ. 4-hydroxyestradiol induces oxidative stress and apoptosis in human mammary epithelial cells: Possible protection by nf-kappab and erk/mapk. Toxicol Appl Pharmacol. 2005. 208: 46-56.   DOI
9 Devanesan P, Todorovic R, Zhao J, Gross ML, Rogan EG, Cavalieri EL. Catechol estrogen conjugates and DNA adducts in the kidney of male syrian golden hamsters treated with 4-hydroxyestradiol: Potential biomarkers for estrogen-initiated cancer. Carcinogenesis. 2001. 22: 489-497.   DOI
10 Fernandez SV, Russo IH, Russo J. Estradiol and its metabolites 4-hydroxyestradiol and 2-hydroxyestradiol induce mutations in human breast epithelial cells. Int J Cancer. 2006. 118: 1862-1868.   DOI
11 Fussell KC, Udasin RG, Smith PJ, Gallo MA, Laskin JD. Catechol metabolites of endogenous estrogens induce redox cycling and generate reactive oxygen species in breast epithelial cells. Carcinogenesis. 2011. 32: 1285-1293.   DOI
12 Gaikwad NW, Yang L, Muti P, Meza JL, Pruthi S, Ingle JN, Rogan EG, Cavalieri EL. The molecular etiology of breast cancer: Evidence from biomarkers of risk. Int J Cancer. 2008. 122: 1949-1957.
13 Kwon YJ, Baek HS, Ye DJ, Shin S, Kim D, Chun YJ. Cyp1b1 enhances cell proliferation and metastasis through induction of emt and activation of wnt/beta-catenin signaling via sp1 upregulation. PLoS One. 2016. 11: e0151598.   DOI
14 Gao N, Nester RA, Sarkar MA. 4-hydroxy estradiol but not 2- hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor a through phosphatidylinositol 3-kinase/akt/frap pathway in ovcar-3 and a2780-cp70 human ovarian carcinoma cells. Toxicol Appl Pharmacol. 2004. 196: 124-135.   DOI
15 Hiraku Y, Yamashita N, Nishiguchi M, Kawanishi S. Catechol estrogens induce oxidative DNA damage and estradiol enhances cell proliferation. Int J Cancer. 2001. 92: 333-337.   DOI
16 Khan WA, Alam K, Moinuddin. Catechol-estrogen modified DNA: A better antigen for cancer autoantibody. Arch Biochem Biophys. 2007. 465: 293-300.   DOI
17 Lareef MH, Garber J, Russo PA, Russo IH, Heulings R, Russo J. The estrogen antagonist ici-182-780 does not inhibit the transformation phenotypes induced by 17-beta-estradiol and 4-oh estradiol in human breast epithelial cells. Int J Oncol. 2005. 26: 423-429.
18 Lewis JS, Thomas TJ, Klinge CM, Gallo MA, Thomas T. Regulation of cell cycle and cyclins by 16alpha-hydroxyestrone in mcf-7 breast cancer cells. J Mol Endocrinol. 2001. 27: 293 -307.   DOI
19 Li KM, Todorovic R, Devanesan P, Higginbotham S, Kofeler H, Ramanathan R, Gross ML, Rogan EG, Cavalieri EL. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female aci rat mammary gland in vivo. Carcinogenesis. 2004. 25: 289-297.
20 Liehr JG, Fang WF, Sirbasku DA, Ari-Ulubelen A. Carcinogenicity of catechol estrogens in syrian hamsters. J Steroid Biochem. 1986. 24: 353-356.   DOI
21 Lukong KE. Understanding breast cancer - the long and winding road. BBA Clin. 2017. 7: 64-77.   DOI
22 Liehr JG, Ricci MJ. 4-hydroxylation of estrogens as marker of human mammary tumors. Proc Natl Acad Sci U S A. 1996. 93: 3294-3296.   DOI
23 Liehr JG, Roy D. Free radical generation by redox cycling of estrogens. Free Radic Biol Med. 1990. 8: 415-423.   DOI
24 Lottering ML, Haag M, Seegers JC. Effects of 17 beta-estradiol metabolites on cell cycle events in mcf-7 cells. Cancer Res. 1992. 52: 5926-5932.
25 Mailander PC, Meza JL, Higginbotham S, Chakravarti D. Induction of a.T to g.C mutations by erroneous repair of depurinated DNA following estrogen treatment of the mammary gland of aci rats. J Steroid Biochem Mol Biol. 2006. 101: 204-215.   DOI
26 Mense SM, Singh B, Remotti F, Liu X, Bhat HK. Vitamin c and alpha-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female aci rats. Carcinogenesis. 2009. 30: 1202-1208.   DOI
27 Murray GI, Taylor MC, McFadyen MC, McKay JA, Greenlee WF, Burke MD, Melvin WT. Tumor-specific expression of cytochrome p450 cyp1b1. Cancer Res. 1997. 57: 3026-3031.
28 Newbold RR, Liehr JG. Induction of uterine adenocarcinoma in cd-1 mice by catechol estrogens. Cancer Res. 2000. 60: 235-237.
29 Nutter LM, Wu YY, Ngo EO, Sierra EE, Gutierrez PL, Abul-Hajj YJ. An o-quinone form of estrogen produces free radicals in human breast cancer cells: Correlation with DNA damage. Chem Res Toxicol. 1994. 7: 23-28.   DOI
30 Okoh VO, Felty Q, Parkash J, Poppiti R, Roy D. Reactive oxygen species via redox signaling to pi3k/akt pathway contribute to the malignant growth of 4-hydroxy estradiol-transformed mam- mary epithelial cells. PLoS One. 2013. 8: e54206.   DOI
31 Raftogianis R, Creveling C, Weinshilboum R, Weisz J. Estrogen metabolism by conjugation. J Natl Cancer Inst Monogr. 2000. 113-124.
32 Paquette B, Bisson M, Baptiste C, Therriault H, Lemay R, Cantin AM. Invasiveness of breast cancer cells mda-mb-231 through extracellular matrix is increased by the estradiol metabolite 4-hydroxyestradiol. Int J Cancer. 2005. 113: 706-711.   DOI
33 Paquette B, Bisson M, Therriault H, Lemay R, Pare M, Banville P, Cantin AM. Activation of matrix metalloproteinase-2 and -9 by 2- and 4-hydroxyestradiol. J Steroid Biochem Mol Biol. 2003. 87: 65-73.   DOI
34 Park SA, Na HK, Kim EH, Cha YN, Surh YJ. 4-hydroxyestradiol induces anchorage-independent growth of human mammary epithelial cells via activation of ikappab kinase: Potential role of reactive oxygen species. Cancer Res. 2009. 69: 2416-2424.   DOI
35 Rogan EG, Badawi AF, Devanesan PD, Meza JL, Edney JA, West WW, Higginbotham SM, Cavalieri EL. Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: Potential biomarkers of susceptibility to cancer. Carcinogenesis. 2003. 24: 697-702.   DOI
36 Singh S, Chakravarti D, Edney JA, Hollins RR, Johnson PJ, West WW, Higginbotham SM, Cavalieri EL, Rogan EG. Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma. Oncol Rep. 2005. 14: 1091-1096.
37 Roy D, Liehr JG. Temporary decrease in renal quinone reductase activity induced by chronic administration of estradiol to male syrian hamsters. Increased superoxide formation by redox cycling of estrogen. J Biol Chem. 1988. 263: 3646-3651.
38 Russo J, Hasan Lareef M, Balogh G, Guo S, Russo IH. Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J Steroid Biochem Mol Biol. 2003. 87: 1-25.   DOI
39 Saeed M, Rogan E, Fernandez SV, Sheriff F, Russo J, Cavalieri E. Formation of depurinating n3adenine and n7guanine adducts by mcf-10f cells cultured in the presence of 4-hydroxyestradiol. Int J Cancer. 2007. 120: 1821-1824.   DOI
40 Seeger H, Wallwiener D, Kraemer E, Mueck AO. Comparison of possible carcinogenic estradiol metabolites: Effects on pro- liferation, apoptosis and metastasis of human breast cancer cells. Maturitas. 2006. 54: 72-77.   DOI
41 Todorovic R, Devanesan P, Higginbotham S, Zhao J, Gross ML, Rogan EG, Cavalieri EL. Analysis of potential biomarkers of estrogen-initiated cancer in the urine of syrian golden hamsters treated with 4-hydroxyestradiol. Carcinogenesis. 2001. 22: 905-911.   DOI
42 Turan VK, Sanchez RI, Li JJ, Li SA, Reuhl KR, Thomas PE, Conney AH, Gallo MA, Kauffman FC, Mesia-Vela S. The effects of steroidal estrogens in aci rat mammary carcinogenesis: 17beta-estradiol, 2-hydroxyestradiol, 4-hydroxyestradiol, 16alpha-hydroxyestradiol, and 4-hydroxyestrone. J Endocrinol. 2004. 183: 91-99.   DOI
43 Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D. Estrogens as endogenous genotoxic agents--DNA adducts and mutations. J Natl Cancer Inst Monogr. 2000. 75-93.
44 Belous AR, Hachey DL, Dawling S, Roodi N, Parl FF. Cytochrome p450 1b1-mediated estrogen metabolism results in estrogen-deoxyribonucleoside adduct formation. Cancer Res. 2007. 67: 812-817.   DOI
45 Castagnetta LA, Granata OM, Traina A, Ravazzolo B, Amoroso M, Miele M, Bellavia V, Agostara B, Carruba G. Tissue content of hydroxyestrogens in relation to survival of breast cancer patients. Clin Cancer Res. 2002. 8: 3146-3155.
46 Cavalieri E, Chakravarti D, Guttenplan J, Hart E, Ingle J, Jankowiak R, Muti P, Rogan E, Russo J, Santen R, Sutter T. Catechol estrogen quinones as initiators of breast and other human cancers: Implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta. 2006. 1766: 63-78.
47 Cavalieri E, Rogan E. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: Keynote lecture. Ann N Y Acad Sci. 2006. 1089: 286-301.   DOI
48 Cavalieri EL, Rogan EG. Depurinating estrogen-DNA adducts, generators of cancer initiation: Their minimization leads to cancer prevention. Clin Transl Med. 2016. 5: 12.   DOI
49 Wen C, Wu L, Fu L, Wang B, Zhou H. Unifying mechanism in the initiation of breast cancer by metabolism of estrogen (review). Mol Med Rep. 2017. 16: 1001-1006.   DOI
50 Wahba HA, El-Hadaad HA. Current approaches in treatment of triple-negative breast cancer. Cancer Biol Med. 2015. 12: 106 -116.
51 Yager JD. Catechol-o-methyltransferase: Characteristics, polymorphisms and role in breast cancer. Drug Discov Today Dis Mech. 2012. 9: e41-e46.
52 Zahid M, Kohli E, Saeed M, Rogan E, Cavalieri E. The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: Implications for tumor-initiating activity. Chem Res Toxicol. 2006. 19: 164-172.   DOI